A peptide encompassing the conserved hydrophobic region and the first β-strand of the prion protein (PrP(110-136)) shown to interact with the surface of dodecylphosphocholine micelles adopts an α-helical conformation that is localized below the head-group layer. This surface-bound peptide has a half-life of one day, and readily initiates the formation of amyloid fibrils. The presence of the latter was confirmed using birefringence microscopy upon Congo red binding and thioflavin T-binding induced fluorescence. The observation of this metastable α-helical conformer provides a unique snapshot of the early steps of the inter-conversion pathway. These findings together with the body of evidence from the prion literature allowed us to propose a ...
A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal...
Conformational switching of the prion protein (PrP) from an α-helical normal cellular form (PrP<sup>...
The principal event underlying the development of prion disease is the conversion of soluble cellula...
A peptide encompassing the conserved hydrophobic region and the first β-strand of the prion protein ...
AbstractConformational transitions are thought to be the prime mechanism of amyloid formation in pri...
AbstractThe prion protein (PrP) peptide 106–126 forms amyloid aggregates in vitro and this sequence ...
The conversion of the alpha-helical, cellular isoform of the prion protein (PrP(C)) to the insoluble...
The prion protein (PrPC) is a glycoprotein of unknown function normally found at the surface...
In vivo under pathological conditions, the normal cellular form of the prion protein, PrP(C) (residu...
The conformational conversion of the cellular prion protein (PrPC) into a misfolded, aggregated and ...
In prion diseases, the mammalian prion protein PrP is converted from a monomeric, mainly α-helical s...
SummaryPeptides comprising residues 106–126 of the human prion protein (PrP) exhibit many features o...
In a previous work by Alvarez-Martinez et al. (2011), the authors pointed out some fallacies in the ...
The principal event underlying the development of prion disease is the conversion of soluble cellula...
The conformational conversion of the cellular prion protein (PrPC) into a misfolded, aggregated and ...
A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal...
Conformational switching of the prion protein (PrP) from an α-helical normal cellular form (PrP<sup>...
The principal event underlying the development of prion disease is the conversion of soluble cellula...
A peptide encompassing the conserved hydrophobic region and the first β-strand of the prion protein ...
AbstractConformational transitions are thought to be the prime mechanism of amyloid formation in pri...
AbstractThe prion protein (PrP) peptide 106–126 forms amyloid aggregates in vitro and this sequence ...
The conversion of the alpha-helical, cellular isoform of the prion protein (PrP(C)) to the insoluble...
The prion protein (PrPC) is a glycoprotein of unknown function normally found at the surface...
In vivo under pathological conditions, the normal cellular form of the prion protein, PrP(C) (residu...
The conformational conversion of the cellular prion protein (PrPC) into a misfolded, aggregated and ...
In prion diseases, the mammalian prion protein PrP is converted from a monomeric, mainly α-helical s...
SummaryPeptides comprising residues 106–126 of the human prion protein (PrP) exhibit many features o...
In a previous work by Alvarez-Martinez et al. (2011), the authors pointed out some fallacies in the ...
The principal event underlying the development of prion disease is the conversion of soluble cellula...
The conformational conversion of the cellular prion protein (PrPC) into a misfolded, aggregated and ...
A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal...
Conformational switching of the prion protein (PrP) from an α-helical normal cellular form (PrP<sup>...
The principal event underlying the development of prion disease is the conversion of soluble cellula...